NCT06139211 2024-12-20A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid TumorsShanghai Junshi Bioscience Co., Ltd.Phase 1/2 Recruiting186 enrolled
NCT04934514 2024-02-20Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid TumorsSUNHO(China)BioPharmaceutical CO., Ltd.Phase 1/2 Unknown97 enrolled
NCT05525247 2023-09-21A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in CombinationSelecxinePhase 1/2 Recruiting420 enrolled